E8V-10781-75905
2 vaccinations
7 coded responses
26 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 946 / CA
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-13
Registered in v-safe
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate increased — Feeling: Good · Site: PainFree text: My heart rate has been a little higher than usualMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Pruritus — Feeling: Good · Site: Pain, Itching · Joint pains, Rash, not including the immediate area around the injection siteFree text: Some itchy spots on my opposite arm and leg. Opposite elbow was achy for a few hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
- 2021-04-17
- 2021-04-19
-
2021-04-26
Survey response — day 14, dose 1MedDRA: Aura, Fatigue, Headache — Feeling: FairFree text: Headache, fatigue, short aura in vision (glowing squiggly line in left eye)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-03
- 2021-05-10
-
2021-05-17
Survey response — day 35, single doseMedDRA: Intermenstrual bleeding, Menstrual clots — Feeling: FairFree text: Heavy breakthrough bleeding. On birth control, take regularly on an extended cycle (12 weeks active, 1 week active). At end of 3rd active week (5/15/21), started heavy flow with medium sized clots appearing every 1-2 hours, continuing through today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Survey response — day 42, single doseMedDRA: Intermenstrual bleeding, Menometrorrhagia, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Dr. did ultrasound for irregular bleeding- looked normal. Have had some spotting since then. Some lower back pain/aches, menstrual crampingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Report sent to call center — day 42, single doseGet care from a doctor or other healthcare professional1 call case(s)
- 2021-06-03
- 2021-07-12
- 2021-10-11
-
2021-10-30
Dose 2 — Pfizer-BioNTech
- 2021-11-01
-
2021-11-02
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
- 2021-11-04
- 2021-11-07
- 2021-11-13
- 2021-11-20
- 2021-11-29
- 2021-12-04
- 2021-12-11
- 2022-01-29
-
2022-05-02
Survey response — 6 months, dose 2MedDRA: Dyspnoea — Feeling: FairFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-10-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): My heart rate has been a little higher than usual
Systemic reaction (other): Some itchy spots on my opposite arm and leg. Opposite elbow was achy for a few hours
Release 8 — day 14, dose 1
Symptoms: Headache, fatigue, short aura in vision (glowing squiggly line in left eye)
Release 8 — day 35, single dose
Symptoms: Heavy breakthrough bleeding. On birth control, take regularly on an extended cycle (12 weeks active, 1 week active). At end of 3rd active week (5/15/21), started heavy flow with medium sized clots appearing every 1-2 hours, continuing through today. cut off by CDC
Release 8 — day 42, single dose
Symptoms: Dr. did ultrasound for irregular bleeding- looked normal. Have had some spotting since then. Some lower back pain/aches, menstrual cramping
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose
Release 11 — 6 months, dose 2
Symptoms: Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aura | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SD | Menometrorrhagia | ✓ | ✓ | ✓ |
| SD | Menstrual clots | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release